To find out which antibody titers targeting different regions of the spike protein (anti-trimeric spike protein, S1, or RBD) were specifically associated with neutralizing serum activity, we performed a ROC analysis in HD patients receiving four doses of a mRNA vaccine. Here, PSMD1 is linked to Huntington disease.